Insulin glargine and lixisenatide Subcutaneous and Zembrace SymTouch
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Zembrace SymTouch and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: sumatriptan
Brand name: Imitrex, Imitrex STATdose, SUMAtriptan Succinate Syringe, Sumavel DosePro, Zembrace SymTouch, Alsuma, Imitrex Statdose Refill, ONZETRA Xsail, Imitrex<, Tosymra, Zecuity
Synonyms: Zembrace SymTouch (injection), Zembrace Symtouch
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Zembrace SymTouch injection
- Insulin glargine and lixisenatide Subcutaneous-Zemdri
- Insulin glargine and lixisenatide Subcutaneous-Zemplar
- Insulin glargine and lixisenatide Subcutaneous-Zemplar (Paricalcitol Capsules)
- Insulin glargine and lixisenatide Subcutaneous-Zemplar (Paricalcitol Injection)
- Insulin glargine and lixisenatide Subcutaneous-Zemplar Injection
- Zembrace SymTouch-Insulin glargine, recombinant Subcutaneous
- Zembrace SymTouch-Insulin glulisine
- Zembrace SymTouch-Insulin Glulisine (Cartridges and Pens)
- Zembrace SymTouch-Insulin Glulisine (Vials)
- Zembrace SymTouch-Insulin glulisine Subcutaneous
- Zembrace SymTouch-Insulin human inhaled Inhalation